{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T11:41:55Z","timestamp":1777894915568,"version":"3.51.4"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004189","name":"Max-Planck-Gesellschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004189","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["107540325 \\u2013 TRR 79"],"award-info":[{"award-number":["107540325 \\u2013 TRR 79"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["107540325"],"award-info":[{"award-number":["107540325"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Biomaterialia"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.actbio.2019.07.018","type":"journal-article","created":{"date-parts":[[2019,7,11]],"date-time":"2019-07-11T20:10:47Z","timestamp":1562875847000},"page":"258-270","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Hyaluronan hydrogels delivering BMP-6 for local targeting of malignant plasma cells and osteogenic differentiation of mesenchymal stromal cells"],"prefix":"10.1016","volume":"96","author":[{"given":"Anna Luise","family":"Grab","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anja","family":"Seckinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Horn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0806-5223","authenticated-orcid":false,"given":"Dirk","family":"Hose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabetta Ada","family":"Cavalcanti-Adam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"18","key":"10.1016\/j.actbio.2019.07.018_b0005","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1056\/NEJMra041875","article-title":"Multiple myeloma","volume":"351","author":"Kyle","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.actbio.2019.07.018_b0010","doi-asserted-by":"crossref","DOI":"10.1093\/annonc\/mdx373.041","article-title":"A multicenter, randomized, phase 3 study of pomalidomide and dexamethasone (Pom-dex) with or without daratumumab in patients with relapsed or refractory multiple myeloma (RRMM): APOLLO","volume":"28","author":"Terpos","year":"2017","journal-title":"Ann. Oncol."},{"issue":"11","key":"10.1016\/j.actbio.2019.07.018_b0015","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1002\/cncr.20652","article-title":"Incidence of multiple myeloma in Olmsted County, Minnesota \u2013 trend over 6 decades","volume":"101","author":"Kyle","year":"2004","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.actbio.2019.07.018_b0020","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41408-017-0037-4","article-title":"Pathogenesis of bone disease in multiple myeloma: from bench to bedside","volume":"8","author":"Terpos","year":"2018","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.actbio.2019.07.018_b0025","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.3389\/fimmu.2018.01822","article-title":"Osteoclast immunosuppressive effects in multiple myeloma: role of programmed cell death ligand 1","volume":"9","author":"Tai","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.actbio.2019.07.018_b0030","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.bone.2015.02.021","article-title":"Dynamic interplay between bone and multiple myeloma: emerging roles of the osteoblast","volume":"75","author":"Reagan","year":"2015","journal-title":"Bone"},{"key":"10.1016\/j.actbio.2019.07.018_b0035","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/289458","article-title":"Cellular mechanisms of multiple myeloma bone disease","author":"Oranger","year":"2013","journal-title":"Clin. Dev. Immunol."},{"issue":"8","key":"10.1016\/j.actbio.2019.07.018_b0040","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1002\/cncr.22991","article-title":"Pathologic fractures correlate with reduced survival in patients with malignant bone disease","volume":"110","author":"Saad","year":"2007","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/j.actbio.2019.07.018_b0045","doi-asserted-by":"crossref","first-page":"e419","DOI":"10.3324\/haematol.2016.144477","article-title":"Bone healing in multiple myeloma: a prospective evaluation of the impact of first-line anti-myeloma treatment","volume":"101","author":"Hinge","year":"2016","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.actbio.2019.07.018_b0050","doi-asserted-by":"crossref","first-page":"170","DOI":"10.2214\/AJR.12.10367","article-title":"Increasing bone sclerosis during bortezomib therapy in multiple myeloma patients: results of a reduced-dose whole-body MDCT study","volume":"202","author":"Schulze","year":"2014","journal-title":"AJR Am. J. Roentgenol."},{"issue":"4","key":"10.1016\/j.actbio.2019.07.018_b0055","first-page":"300","article-title":"Myeloma and bone disease: \u201cthe dangerous tango\u201d","volume":"4","author":"Epstein","year":"2006","journal-title":"Clin. Adv. Hematol. Oncol."},{"issue":"4","key":"10.1016\/j.actbio.2019.07.018_b0060","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.cell.2006.06.044","article-title":"Matrix elasticity directs stem cell lineage specification","volume":"126","author":"Engler","year":"2006","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.actbio.2019.07.018_b0065","first-page":"67","article-title":"Characterization of multiple myeloma clonal cell expansion and stromal Wnt\/beta-catenin signaling in hyaluronic acid-based 3D hydrogel","volume":"28","author":"Narayanan","year":"2014","journal-title":"In Vivo"},{"key":"10.1016\/j.actbio.2019.07.018_b0070","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-018-0615-3","article-title":"Wnt signaling in multiple myeloma: a central player in disease with therapeutic potential","volume":"11","author":"Spaan","year":"2018","journal-title":"J. Hematol. Oncol."},{"issue":"6","key":"10.1016\/j.actbio.2019.07.018_b0075","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1084\/jem.20031454","article-title":"Sclerostin is an osteocyte-expressed negative regulator of bone formation, but not a classical BMP antagonist","volume":"199","author":"van Bezooijen","year":"2004","journal-title":"J. Exp. Med."},{"issue":"44","key":"10.1016\/j.actbio.2019.07.018_b0080","doi-asserted-by":"crossref","first-page":"3866","DOI":"10.1038\/onc.2009.257","article-title":"Bone morphogenic protein 6: a member of a novel class of prognostic factors expressed by normal and malignant plasma cells inhibiting proliferation and angiogenesis","volume":"28","author":"Seckinger","year":"2009","journal-title":"Oncogene"},{"issue":"26","key":"10.1016\/j.actbio.2019.07.018_b0085","doi-asserted-by":"crossref","first-page":"3452","DOI":"10.1182\/blood-2017-03-773341","article-title":"Inhibiting the osteocyte-specific protein sclerostin increases bone mass and fracture resistance in multiple myeloma","volume":"129","author":"McDonald","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.actbio.2019.07.018_b0090","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.biomaterials.2015.07.021","article-title":"Structural and functional insights into sclerostin-glycosaminoglycan interactions in bone","volume":"67","author":"Salbach-Hirsch","year":"2015","journal-title":"Biomaterials"},{"issue":"6","key":"10.1016\/j.actbio.2019.07.018_b0095","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1002\/jcp.23010","article-title":"The transcription factor osterix (SP7) Regulates BMP-6-induced human osteoblast differentiation","volume":"227","author":"Zhu","year":"2012","journal-title":"J. Cell. Physiol."},{"issue":"8","key":"10.1016\/j.actbio.2019.07.018_b0100","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.2106\/00004623-200308000-00017","article-title":"Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs)","volume":"85-a","author":"Cheng","year":"2003","journal-title":"J. Bone Joint Surg. Am."},{"issue":"26","key":"10.1016\/j.actbio.2019.07.018_b0105","doi-asserted-by":"crossref","first-page":"6113","DOI":"10.1016\/j.biomaterials.2012.05.030","article-title":"Hyaluronic acid-based hydrogels functionalized with heparin that support controlled release of bioactive BMP-2","volume":"33","author":"Bhakta","year":"2012","journal-title":"Biomaterials"},{"issue":"17","key":"10.1016\/j.actbio.2019.07.018_b0110","doi-asserted-by":"crossref","first-page":"5306","DOI":"10.1021\/ja068768s","article-title":"Membrane-grafted hyaluronan films: a well-defined model system of glycoconjugate cell coats","volume":"129","author":"Richter","year":"2007","journal-title":"J. Am. Chem. Soc."},{"issue":"3","key":"10.1016\/j.actbio.2019.07.018_b0115","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1177\/0885328206051047","article-title":"The effect of hyaluronic acid-supplemented bone graft in bone healing: experimental study in rabbits","volume":"20","author":"Aslan","year":"2006","journal-title":"J. Biomater. Appl."},{"key":"10.1016\/j.actbio.2019.07.018_b0120","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jmbbm.2015.06.023","article-title":"Mechanics of intact bone marrow","volume":"50","author":"Jansen","year":"2015","journal-title":"J. Mech. Behav. Biomed. Mater."},{"issue":"12","key":"10.1016\/j.actbio.2019.07.018_b0125","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.bbapap.2012.07.002","article-title":"Prediction of heparin binding sites in bone morphogenetic proteins (BMPs)","volume":"1824","author":"Gandhi","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"issue":"3","key":"10.1016\/j.actbio.2019.07.018_b0130","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s00264-012-1714-3","article-title":"Exogenous heparin binds and inhibits bone morphogenetic protein 6 biological activity","volume":"37","author":"Brkljacic","year":"2013","journal-title":"Int. Orthop."},{"issue":"6","key":"10.1016\/j.actbio.2019.07.018_b0135","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1210\/endo.136.6.7750491","article-title":"The effects of bone morphogenetic protein-2, protein-4, and protein-6 on differentiation of rat osteoblast cells in-vitro","volume":"136","author":"Hughes","year":"1995","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.actbio.2019.07.018_b0140","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/jbm.b.31255","article-title":"Enhancement of bone formation in hydroxyapatite implants by rhBMP-2 coating","volume":"90","author":"Schnettler","year":"2009","journal-title":"J. Biomed. Mater. Res. B Appl. Biomater."},{"issue":"4","key":"10.1016\/j.actbio.2019.07.018_b0145","doi-asserted-by":"crossref","first-page":"1600041","DOI":"10.1002\/adbi.201600041","article-title":"Enhanced biological activity of BMP-2 bound to surface-grafted heparan sulfate","volume":"1","author":"Migliorini","year":"2017","journal-title":"Adv. Biosyst."},{"key":"10.1016\/j.actbio.2019.07.018_b0150","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.biomaterials.2016.04.013","article-title":"Sulfated hyaluronan improves bone regeneration of diabetic rats by binding sclerostin and enhancing osteoblast function","volume":"96","author":"Picke","year":"2016","journal-title":"Biomaterials"},{"issue":"16","key":"10.1016\/j.actbio.2019.07.018_b0155","doi-asserted-by":"crossref","first-page":"10890","DOI":"10.1074\/jbc.M807994200","article-title":"Characterization of the structural features and interactions of sclerostin: molecular insight into a key regulator of Wnt-mediated bone formation","volume":"284","author":"Veverka","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.actbio.2019.07.018_b0160","article-title":"Covalent binding of BMP-2 on surfaces using a self-assembled monolayer approach","volume":"78","author":"Pohl","year":"2013","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.actbio.2019.07.018_b0165","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.snb.2017.05.075","article-title":"Integration of core\/shell nanoparticle and QCM-D sensors in a single device: a new approach to the in situ detection of solvent content in thin adsorbed films with minimized response to spurious bulk refractive index changes","volume":"251","author":"Grab","year":"2017","journal-title":"Sens. Actuators, B"},{"key":"10.1016\/j.actbio.2019.07.018_b0170","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1238\/Physica.Regular.059a00391","article-title":"Viscoelastic acoustic response of layered polymer films at fluid-solid interfaces: continuum mechanics approach","volume":"59","author":"Vionova","year":"1999","journal-title":"Phys. Scr."},{"issue":"2","key":"10.1016\/j.actbio.2019.07.018_b0175","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/BF01337937","article-title":"Verwendung von Schwingquarzen zur W\u00e4gung d\u00fcnner Schichten und zur Mikrow\u00e4gung","volume":"155","author":"Sauerbrey","year":"1959","journal-title":"Z. Phys."},{"issue":"3","key":"10.1016\/j.actbio.2019.07.018_b0180","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.ccell.2017.02.002","article-title":"Target expression, generation, preclinical activity, and pharmacokinetics of the BCMA-T cell bispecific antibody EM801 for multiple myeloma treatment","volume":"31","author":"Seckinger","year":"2017","journal-title":"Cancer Cell"},{"issue":"5","key":"10.1016\/j.actbio.2019.07.018_b0185","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1182\/blood-2012-03-415588","article-title":"Clinical and prognostic role of annexin A2 in multiple myeloma","volume":"120","author":"Seckinger","year":"2012","journal-title":"Blood"},{"issue":"18","key":"10.1016\/j.actbio.2019.07.018_b0190","doi-asserted-by":"crossref","first-page":"4331","DOI":"10.1182\/blood-2008-09-178350","article-title":"Inhibition of aurora kinases for tailored risk-adapted treatment of multiple myeloma","volume":"113","author":"Hose","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.actbio.2019.07.018_b0195","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.01676","article-title":"CD38 as immunotherapeutic target in light chain amyloidosis and multiple myeloma-association with molecular entities, risk, survival, and mechanisms of upfront resistance","volume":"9","author":"Seckinger","year":"2018","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.actbio.2019.07.018_b0200","first-page":"484","article-title":"Proliferation is a central independent prognostic factor and target for personalized and risk-adapted treatment in multiple myeloma","volume":"96","author":"Hose","year":"2011","journal-title":"Haematologica"},{"issue":"11","key":"10.1016\/j.actbio.2019.07.018_b0205","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1016\/j.yexcr.2010.03.013","article-title":"Bone marrow stromal cell interaction reduces syndecan-1 expression and induces kinomic changes in myeloma cells","volume":"316","author":"Fuhler","year":"2010","journal-title":"Exp. Cell Res."},{"issue":"3","key":"10.1016\/j.actbio.2019.07.018_b0210","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1021\/acs.nanolett.5b00315","article-title":"Nanoscale control of surface immobilized BMP-2: toward a quantitative assessment of BMP-mediated signaling events","volume":"15","author":"Schwab","year":"2015","journal-title":"Nano Lett."},{"key":"10.1016\/j.actbio.2019.07.018_b0215","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1749-6632.2011.06196.x","article-title":"Sclerostin is overexpressed by plasma cells from multiple myeloma patients","volume":"1237","author":"Brunetti","year":"2011","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"1","key":"10.1016\/j.actbio.2019.07.018_b0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/15476278.2015.1019687","article-title":"Tissue stiffness dictates development, homeostasis, and disease progression","volume":"11","author":"Handorf","year":"2015","journal-title":"Organogenesis"},{"issue":"6","key":"10.1016\/j.actbio.2019.07.018_b0225","doi-asserted-by":"crossref","first-page":"3298","DOI":"10.1021\/la060500r","article-title":"Viscoelastic properties of fibrinogen adsorbed to the surface of biomaterials used in blood-contacting medical devices","volume":"23","author":"Weber","year":"2007","journal-title":"Langmuir"},{"issue":"17","key":"10.1016\/j.actbio.2019.07.018_b9000","doi-asserted-by":"crossref","first-page":"3024","DOI":"10.1038\/sj.onc.1207386","article-title":"Bone morphogenetic protein-5, -6 and -7 inhibit growth and induce apoptosis in human myeloma cells","volume":"23","author":"Ro","year":"2004","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.actbio.2019.07.018_b0230","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.ijrobp.2018.05.009","article-title":"Radiation therapy for solitary plasmacytoma and multiple myeloma: guidelines from the international lymphoma radiation oncology group","volume":"101","author":"Tsang","year":"2018","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"3","key":"10.1016\/j.actbio.2019.07.018_b0235","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1002\/jbm.b.33931","article-title":"Drug Release as a function of bioactivity, incubation regime, liquid, and initial load: Release of bortezomib from calcium phosphate-containing silica\/collagen xerogels","volume":"106","author":"Kruppke","year":"2018","journal-title":"J. Biomed. Mater. Res. B Appl. Biomater."},{"issue":"9","key":"10.1016\/j.actbio.2019.07.018_b0240","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1002\/mabi.201500085","article-title":"Dendritic glycopolymer as drug delivery system for proteasome inhibitor bortezomib in a calcium phosphate bone cement: first steps toward a local therapy of osteolytic bone lesions","volume":"15","author":"Striegler","year":"2015","journal-title":"Macromol. Biosci."},{"key":"10.1016\/j.actbio.2019.07.018_b0245","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2172-6-9","article-title":"BMP-6 inhibits growth of mature human B cells; induction of Smad phosphorylation and upregulation of Id1","volume":"6","author":"Kersten","year":"2005","journal-title":"BMC Immunol."},{"issue":"1","key":"10.1016\/j.actbio.2019.07.018_b0250","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1021\/acsnano.8b05286","article-title":"Soft hyaluronic gels promote cell spreading, stress fibers, focal adhesion, and membrane tension by phosphoinositide signaling, not traction force","volume":"13","author":"Mandal","year":"2019","journal-title":"ACS Nano"},{"issue":"12","key":"10.1016\/j.actbio.2019.07.018_b0255","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1016\/j.biomaterials.2013.01.035","article-title":"Low dose BMP-2 treatment for bone repair using a PEGylated fibrinogen hydrogel matrix","volume":"34","author":"Ben-David","year":"2013","journal-title":"Biomaterials"},{"issue":"10","key":"10.1016\/j.actbio.2019.07.018_b0260","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1007\/s10856-017-5974-8","article-title":"Alginate\/hyaluronic acid hydrogel delivery system characteristics regulate the differentiation of periodontal ligament stem cells toward chondrogenic lineage","volume":"28","author":"Ansari","year":"2017","journal-title":"J. Mater. Sci. Mater. Med."},{"issue":"36","key":"10.1016\/j.actbio.2019.07.018_b0265","doi-asserted-by":"crossref","first-page":"9698","DOI":"10.1016\/j.biomaterials.2014.07.065","article-title":"Rapidly polymerizing injectable click hydrogel therapy to delay bone growth in a murine re-synostosis model","volume":"35","author":"Hermann","year":"2014","journal-title":"Biomaterials"},{"issue":"20","key":"10.1016\/j.actbio.2019.07.018_b0270","doi-asserted-by":"crossref","first-page":"5294","DOI":"10.1016\/j.biomaterials.2014.02.040","article-title":"The synergetic effect of hydrogel stiffness and growth factor on osteogenic differentiation","volume":"35","author":"Tan","year":"2014","journal-title":"Biomaterials"},{"issue":"37","key":"10.1016\/j.actbio.2019.07.018_b0275","doi-asserted-by":"crossref","first-page":"14371","DOI":"10.1074\/jbc.RA118.003191","article-title":"Domains with highest heparan sulfate-binding affinity reside at opposite ends in BMP2\/4 versus BMP5\/6\/7: implications for function","volume":"293","author":"Billings","year":"2018","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.actbio.2019.07.018_b0280","article-title":"Enhanced biological activity of BMP-2 bound to surface-grafted heparan sulfate, advanced","volume":"1","author":"Migliorini","year":"2017","journal-title":"Biosystems"},{"key":"10.1016\/j.actbio.2019.07.018_b0285","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.cytogfr.2015.11.008","article-title":"Tuning cellular responses to BMP-2 with material surfaces","volume":"27","author":"Migliorini","year":"2016","journal-title":"Cytokine Growth Factor Rev."},{"issue":"28","key":"10.1016\/j.actbio.2019.07.018_b0290","doi-asserted-by":"crossref","first-page":"7226","DOI":"10.1016\/j.biomaterials.2010.05.022","article-title":"The identification of a heparin binding domain peptide from bone morphogenetic protein-4 and its role on osteogenesis","volume":"31","author":"Choi","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2019.07.018_b0295","doi-asserted-by":"crossref","first-page":"773","DOI":"10.3762\/bjoc.11.87","article-title":"Regulation of integrin and growth factor signaling in biomaterials for osteodifferentiation","volume":"11","author":"Wei","year":"2015","journal-title":"Beilstein J. Org. Chem."},{"key":"10.1016\/j.actbio.2019.07.018_b0300","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.colsurfb.2016.11.029","article-title":"Colloid, adhesive and release properties of nanoparticular ternary complexes between cationic and anionic polysaccharides and basic proteins like bone morphogenetic protein BMP-2","volume":"151","author":"Petzold","year":"2017","journal-title":"Colloids Surf., B"},{"issue":"2","key":"10.1016\/j.actbio.2019.07.018_b0305","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.biomaterials.2010.09.008","article-title":"The effect of immobilization of heparin and bone morphogenic protein-2 (BMP-2) to titanium surfaces on inflammation and osteoblast function","volume":"32","author":"Kim","year":"2011","journal-title":"Biomaterials"},{"issue":"10","key":"10.1016\/j.actbio.2019.07.018_b0310","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s10856-006-0181-z","article-title":"In vivo release of rhBMP-2 loaded porous calcium phosphate cement pretreated with albumin","volume":"17","author":"Ruhe","year":"2006","journal-title":"J. Mater. Sci. Mater. Med."},{"issue":"6","key":"10.1016\/j.actbio.2019.07.018_b0315","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1002\/ijc.27342","article-title":"Elevated circulating sclerostin correlates with advanced disease features and abnormal bone remodeling in symptomatic myeloma: reduction post-bortezomib monotherapy","volume":"131","author":"Terpos","year":"2012","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.actbio.2019.07.018_b0320","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/978-3-540-85772-3_3","article-title":"Molecular pathogenesis of multiple myeloma: chromosomal aberrations, changes in gene expression, cytokine networks, and the bone marrow microenvironment","volume":"183","author":"Klein","year":"2011","journal-title":"Recent Results Cancer Res."},{"issue":"3","key":"10.1016\/j.actbio.2019.07.018_b0325","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.cytogfr.2014.04.009","article-title":"The role of bone morphogenetic proteins in myeloma cell survival","volume":"25","author":"Holien","year":"2014","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.actbio.2019.07.018_b0330","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.3389\/fimmu.2018.01676","article-title":"CD38 as immunotherapeutic target in light chain amyloidosis and multiple myeloma-association with molecular entities risk, survival, and mechanisms of upfront resistance","volume":"9","author":"Seckinger","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.actbio.2019.07.018_b0335","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3389\/fbioe.2015.00062","article-title":"Matrix-immobilized BMP-2 on microcontact printed fibronectin as an in vitro tool to study BMP-mediated signaling and cell migration","volume":"3","author":"Hauff","year":"2015","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"12","key":"10.1016\/j.actbio.2019.07.018_b0340","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.addr.2012.03.010","article-title":"Biomimetic hydrogels for controlled biomolecule delivery to augment bone regeneration","volume":"64","author":"Lienemann","year":"2012","journal-title":"Adv. Drug Delivery Rev."},{"issue":"38","key":"10.1016\/j.actbio.2019.07.018_b0345","doi-asserted-by":"crossref","first-page":"25879","DOI":"10.1074\/jbc.M109.024125","article-title":"Fibronectin binds and enhances the activity of bone morphogenetic protein 1","volume":"284","author":"Huang","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.actbio.2019.07.018_b0350","doi-asserted-by":"crossref","first-page":"7672","DOI":"10.3390\/ijms16047672","article-title":"Design of an osteoinductive extracellular fibronectin matrix protein for bone tissue engineering","volume":"16","author":"Lee","year":"2015","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.actbio.2019.07.018_b0355","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1038\/sj.leu.2404284","article-title":"International uniform response criteria for multiple myeloma","volume":"20","author":"Durie","year":"2006","journal-title":"Leukemia"},{"issue":"4","key":"10.1016\/j.actbio.2019.07.018_b0360","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics10040202","article-title":"Myeloma bone disease: update on pathogenesis and novel treatment strategies","volume":"10","author":"Vallet","year":"2018","journal-title":"Pharmaceutics"}],"container-title":["Acta Biomaterialia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706119304982?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706119304982?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T07:36:37Z","timestamp":1777620997000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1742706119304982"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":73,"alternative-id":["S1742706119304982"],"URL":"https:\/\/doi.org\/10.1016\/j.actbio.2019.07.018","relation":{},"ISSN":["1742-7061"],"issn-type":[{"value":"1742-7061","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hyaluronan hydrogels delivering BMP-6 for local targeting of malignant plasma cells and osteogenic differentiation of mesenchymal stromal cells","name":"articletitle","label":"Article Title"},{"value":"Acta Biomaterialia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actbio.2019.07.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}